Clinical trial

Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal…

NCT00445120 · Campus Bio-Medico University, Other · Completed

Key facts

NCT number NCT00445120
Title Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
Official title Multicenter, Randomised, Double Masked, Controlled Studies on the Efficacy of Lactobacillus Rhamnosus GG Treatment in Preventing Vernal Keratoconjunctivitis VKC) Relapses.
Lead sponsor Campus Bio-Medico University, Other
Collaborators University of Genova University of Padova
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Vernal Keratoconjunctivitis
Intervention type Drug
Interventions Lactobacillus Rhamnosus GG, placebo (sugar)
Enrollment 48
Start date Mar 1, 2007
Primary completion Sep 1, 2008
Completion Jan 1, 2009
First posted Mar 8, 2007
Last update posted Jan 29, 2009
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies